HeartBeam, Inc.
BEAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001779372
No open-market purchases or sales by HeartBeam, Inc. insiders were filed in the last 90 days; 41 institutions reported holding it in 13F filings for Q2 2026, worth $6.08M in total; no superinvestor holds it.
Other share classesBEATW
Q3 2022 vs. Q2 2022
How the institutions holding HeartBeam, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 7 | 13 | +6 |
| Shares | 233.2K | 121.5K | −111.7K (−47.9%) |
| Value | $300.4K | $474.8K | +$174.5K (+58.1%) |
New holders (8)
Institutions that held HeartBeam, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| D'Orazio & Associates, Inc. | 26,500 | $103.0K | 0.03% |
| Cannon Financial Strategists, Inc. | 16,362 | $63.8K | 0.03% |
| Virtu Financial LLC | 16,107 | $63.0K | 0.01% |
| Jane Street Group, LLC | 13,903 | $54.0K | 0.00% |
| Bank of New York Mellon Corp | 12,451 | $49.0K | 0.00% |
| Renaissance Technologies LLC | 12,200 | $48.0K | 0.00% |
| Morgan Stanley | 2,256 | $9.00K | 0.00% |
| UBS Group AG | 492 | $2.00K | 0.00% |
Sold out (2)
Institutions that held HeartBeam, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sabby Management, LLC | 195,000 | $252.0K |
| StoneX Group Inc. | 15,000 | $19.4K |